ArticleThoracic cancer2018

Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non-small cell lung cancer after second-line chemotherapy treatment: A retrospective study.

Di Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.